Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D-Printed Tablets

Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using ste...

Full description

Saved in:
Bibliographic Details
Published inAAPS PharmSciTech Vol. 19; no. 8; pp. 3355 - 3361
Main Authors Martinez, Pamela Robles, Goyanes, Alvaro, Basit, Abdul W., Gaisford, Simon
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.11.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using stereolithographic 3D printing. A number of geometric shapes were produced (cube, disc, pyramid, sphere and torus) with either constant surface area (SA) or constant surface area/volume ratio (SA/V). Dissolution testing showed that printlets with constant SA/V ratio released drug at the same rate, while those with constant SA released drug at different rates. A series of tori with increasing SA/V ratio (from 0.5 to 2.4) were printed, and it was found that dissolution rate increased as the SA/V ratio increased. The data show that printlets can be fabricated in multiple shapes and that dissolution performance can be maintained if the SA/V ratio is constant or that dissolution performance of printlets can be fine-tuned by varying SA/V ratio. The results suggest that 3D printing is therefore a suitable manufacturing method for personalized dosage forms.
AbstractList Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using stereolithographic 3D printing. A number of geometric shapes were produced (cube, disc, pyramid, sphere and torus) with either constant surface area (SA) or constant surface area/volume ratio (SA/V). Dissolution testing showed that printlets with constant SA/V ratio released drug at the same rate, while those with constant SA released drug at different rates. A series of tori with increasing SA/V ratio (from 0.5 to 2.4) were printed, and it was found that dissolution rate increased as the SA/V ratio increased. The data show that printlets can be fabricated in multiple shapes and that dissolution performance can be maintained if the SA/V ratio is constant or that dissolution performance of printlets can be fine-tuned by varying SA/V ratio. The results suggest that 3D printing is therefore a suitable manufacturing method for personalized dosage forms.
Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using stereolithographic 3D printing. A number of geometric shapes were produced (cube, disc, pyramid, sphere and torus) with either constant surface area (SA) or constant surface area/volume ratio (SA/V). Dissolution testing showed that printlets with constant SA/V ratio released drug at the same rate, while those with constant SA released drug at different rates. A series of tori with increasing SA/V ratio (from 0.5 to 2.4) were printed, and it was found that dissolution rate increased as the SA/V ratio increased. The data show that printlets can be fabricated in multiple shapes and that dissolution performance can be maintained if the SA/V ratio is constant or that dissolution performance of printlets can be fine-tuned by varying SA/V ratio. The results suggest that 3D printing is therefore a suitable manufacturing method for personalized dosage forms.Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using stereolithographic 3D printing. A number of geometric shapes were produced (cube, disc, pyramid, sphere and torus) with either constant surface area (SA) or constant surface area/volume ratio (SA/V). Dissolution testing showed that printlets with constant SA/V ratio released drug at the same rate, while those with constant SA released drug at different rates. A series of tori with increasing SA/V ratio (from 0.5 to 2.4) were printed, and it was found that dissolution rate increased as the SA/V ratio increased. The data show that printlets can be fabricated in multiple shapes and that dissolution performance can be maintained if the SA/V ratio is constant or that dissolution performance of printlets can be fine-tuned by varying SA/V ratio. The results suggest that 3D printing is therefore a suitable manufacturing method for personalized dosage forms.
Author Goyanes, Alvaro
Gaisford, Simon
Martinez, Pamela Robles
Basit, Abdul W.
Author_xml – sequence: 1
  givenname: Pamela Robles
  surname: Martinez
  fullname: Martinez, Pamela Robles
  organization: UCL School of Pharmacy, University College London
– sequence: 2
  givenname: Alvaro
  surname: Goyanes
  fullname: Goyanes, Alvaro
  organization: UCL School of Pharmacy, University College London
– sequence: 3
  givenname: Abdul W.
  surname: Basit
  fullname: Basit, Abdul W.
  organization: UCL School of Pharmacy, University College London
– sequence: 4
  givenname: Simon
  surname: Gaisford
  fullname: Gaisford, Simon
  email: s.gaisford@ucl.ac.uk
  organization: UCL School of Pharmacy, University College London
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29948979$$D View this record in MEDLINE/PubMed
BookMark eNp9kbtOJDEQRa0VaHntB2yCHELQ4LL75RAxy0MaCQRsbHnc5Rkjjz3Y7oC_3x4NSCsCoqrgnCtV3SOyF2JAQn4DuwDO-ssMnNeyYtBXwLqmEj_IITSCVVIKvvfffkCOcn5ljAuQ4ic54FLWvezkIdH3wfoRg0EaLb3FuMaS3mkMtKyQztK4pE_oUWekjyla5zFvweeCCaN3ZRWXSW9WztCz5_nVORWz6jG5UHCgL3rhseQTsm-1z_jrYx6Tvzd_Xq7vqvnD7f311bwyNbBS1QK62thW8kEaHPqu1oa1_cCEsEw0MJ0B2JpFbSV0VnOsBy1Y0wHYRtgBxDE52-VuUnwbMRe1dtmg9zpgHLPirGV910DTTujpBzou1jioTXJrnd7V51smoNsBJsWcE1plXNHFxVCSdl4BU9sC1K4ANRWgtgUoMZnwxfwM_87hOydPbFhiUq9xTGF61jfSP1tQle4
CitedBy_id crossref_primary_10_1080_03639045_2021_1994990
crossref_primary_10_1016_j_ijpharm_2024_124506
crossref_primary_10_3390_pharmaceutics12020124
crossref_primary_10_1208_s12249_020_01905_8
crossref_primary_10_1016_j_ijpx_2023_100159
crossref_primary_10_1016_j_bioadv_2022_213100
crossref_primary_10_1016_j_ijpharm_2022_122046
crossref_primary_10_1007_s41669_024_00551_1
crossref_primary_10_2217_3dp_2020_0031
crossref_primary_10_1016_j_ijpharm_2018_11_025
crossref_primary_10_3390_pharmaceutics14040843
crossref_primary_10_1016_j_xphs_2020_06_027
crossref_primary_10_3390_pharmaceutics11100544
crossref_primary_10_1038_s41467_021_21438_3
crossref_primary_10_3390_pharmaceutics14020281
crossref_primary_10_1080_03639045_2019_1576723
crossref_primary_10_22159_ajpcr_2022_v15i8_45136
crossref_primary_10_1016_j_ijpharm_2021_120257
crossref_primary_10_37285_ijpsn_2023_16_1_7
crossref_primary_10_1016_j_xphs_2021_08_030
crossref_primary_10_1108_RPJ_09_2023_0326
crossref_primary_10_1021_acs_langmuir_3c02626
crossref_primary_10_1016_j_ijpharm_2025_125218
crossref_primary_10_1016_j_jddst_2020_101850
crossref_primary_10_1016_j_ijpharm_2018_08_002
crossref_primary_10_1002_VIW_20200126
crossref_primary_10_1016_j_bprint_2023_e00298
crossref_primary_10_1016_j_ijpharm_2022_122574
crossref_primary_10_1115_1_4056199
crossref_primary_10_1016_j_addma_2020_101071
crossref_primary_10_1016_j_ijpharm_2024_124594
crossref_primary_10_1016_j_ejps_2020_105688
crossref_primary_10_1016_j_matchemphys_2024_129692
crossref_primary_10_3390_polym14245413
crossref_primary_10_2174_1381612825666190507115504
crossref_primary_10_3389_fbioe_2023_1256361
crossref_primary_10_1016_j_apsb_2021_03_015
crossref_primary_10_1007_s42242_021_00175_y
crossref_primary_10_3390_pharmaceutics11040148
crossref_primary_10_1016_j_addr_2021_04_020
crossref_primary_10_1089_ten_tea_2019_0278
crossref_primary_10_1016_j_ijpharm_2020_119732
crossref_primary_10_3390_pharmaceutics15092230
crossref_primary_10_29109_gujsc_1601468
crossref_primary_10_1016_j_ijpharm_2019_118471
crossref_primary_10_1016_j_ejpb_2022_06_013
crossref_primary_10_4164_sptj_57_633
crossref_primary_10_3390_app9081713
crossref_primary_10_1208_s12249_019_1538_1
crossref_primary_10_1016_j_bprint_2023_e00289
crossref_primary_10_1016_j_ijpharm_2022_122540
crossref_primary_10_2139_ssrn_4076505
crossref_primary_10_1002_adma_201902516
crossref_primary_10_1016_j_apsb_2021_05_014
crossref_primary_10_1016_j_mtchem_2022_100789
crossref_primary_10_3390_molecules27092784
crossref_primary_10_1080_01932691_2023_2289623
crossref_primary_10_1208_s12249_019_1455_3
crossref_primary_10_1016_j_addr_2021_113921
crossref_primary_10_1016_j_ijpharm_2020_119066
crossref_primary_10_1016_j_sintl_2022_100177
crossref_primary_10_1007_s10856_021_06509_7
crossref_primary_10_1016_j_jconrel_2020_10_008
crossref_primary_10_1088_1758_5090_ad3a14
crossref_primary_10_1016_j_ijpharm_2019_118611
crossref_primary_10_1016_j_mtcomm_2023_105875
crossref_primary_10_3390_pr11123431
crossref_primary_10_1016_j_xphs_2020_08_029
crossref_primary_10_3390_pharmaceutics12090833
crossref_primary_10_1016_j_ijpharm_2019_118494
crossref_primary_10_3390_pharmaceutics12111100
crossref_primary_10_15212_AMM_2021_0010
crossref_primary_10_1016_j_ijpharm_2019_118651
crossref_primary_10_1016_j_ijpharm_2022_121956
crossref_primary_10_1016_j_ijpharm_2023_123058
crossref_primary_10_1021_acs_biomac_4c01004
crossref_primary_10_1016_j_ijpharm_2024_124543
crossref_primary_10_1016_j_stlm_2022_100081
crossref_primary_10_1016_j_foodchem_2024_140348
crossref_primary_10_3390_pharmaceutics11120645
crossref_primary_10_1088_1748_605X_ad2a3a
crossref_primary_10_1016_j_apt_2021_07_022
crossref_primary_10_3390_pharmaceutics15020395
crossref_primary_10_1016_j_ijpharm_2020_119245
crossref_primary_10_1021_acs_jafc_3c02608
crossref_primary_10_1016_j_eurpolymj_2024_113245
crossref_primary_10_1016_j_ijpharm_2025_125415
crossref_primary_10_1016_j_addr_2021_114076
crossref_primary_10_1248_bpb_b23_00443
crossref_primary_10_1007_s42242_021_00157_0
crossref_primary_10_1016_j_ijpharm_2022_122135
crossref_primary_10_3390_ma13214961
crossref_primary_10_3390_pharmaceutics14071312
crossref_primary_10_3390_pharmaceutics15041276
crossref_primary_10_1080_09205063_2021_1967702
crossref_primary_10_1007_s40964_020_00127_5
crossref_primary_10_1208_s12249_019_1400_5
crossref_primary_10_3390_pharmaceutics11060274
crossref_primary_10_3390_pharmaceutics16101285
crossref_primary_10_3390_jmmp9010011
crossref_primary_10_1016_j_mfglet_2024_09_109
crossref_primary_10_1016_j_ijpharm_2019_118790
crossref_primary_10_1016_j_ijpharm_2021_120442
crossref_primary_10_1016_j_bprint_2024_e00360
crossref_primary_10_1016_j_ijpharm_2021_120721
crossref_primary_10_1007_s12247_022_09684_4
crossref_primary_10_1021_acs_langmuir_4c00894
crossref_primary_10_1016_j_mtcomm_2023_107987
crossref_primary_10_3390_pharmaceutics13050616
crossref_primary_10_1016_j_jconrel_2022_09_023
crossref_primary_10_37349_emed_2023_00161
crossref_primary_10_1016_j_ejps_2019_05_008
crossref_primary_10_1080_03639045_2020_1801714
crossref_primary_10_1016_j_ijpharm_2023_122780
crossref_primary_10_3390_ph16111521
crossref_primary_10_1016_j_ijpharm_2018_07_024
crossref_primary_10_1016_j_eurpolymj_2023_112240
crossref_primary_10_1016_j_jddst_2021_102992
crossref_primary_10_3390_pharmaceutics13091524
crossref_primary_10_1016_j_ijpharm_2020_119428
crossref_primary_10_1016_j_jconrel_2019_04_021
crossref_primary_10_3389_fphar_2021_646836
crossref_primary_10_1016_j_ijpharm_2020_119820
crossref_primary_10_3390_pharmaceutics11080390
crossref_primary_10_1080_17425247_2019_1660318
crossref_primary_10_52711_0974_360X_2024_00720
crossref_primary_10_1007_s11095_018_2531_1
crossref_primary_10_1248_bpb_b19_00481
crossref_primary_10_3390_s20174733
crossref_primary_10_1016_j_ijpharm_2023_122895
crossref_primary_10_1016_j_susmat_2022_e00481
crossref_primary_10_1016_j_ijpx_2022_100142
crossref_primary_10_3390_pharmaceutics15071917
crossref_primary_10_3390_pharmaceutics15020416
crossref_primary_10_3390_polym12051105
crossref_primary_10_2174_0113816128309717240826101647
crossref_primary_10_1021_acs_molpharmaceut_2c01061
crossref_primary_10_1016_j_ijpharm_2020_119825
Cites_doi 10.1016/S0939-6411(99)00082-X
10.1016/j.ejpb.2011.01.001
10.1016/j.ijpharm.2016.03.016
10.1016/j.drudis.2018.05.025
10.1081/DDC-120003007
10.1016/j.ijpharm.2015.02.051
10.1023/A:1016218716951
10.1166/jbn.2009.1052
10.1016/j.ijpharm.2017.07.064
10.1016/j.ijpharm.2015.04.069
10.1023/A:1015834114359
10.1016/S0014-827X(02)01297-1
10.1016/j.ijpharm.2018.02.015
10.1016/J.IJPHARM.2017.06.082
10.1016/S0928-0987(98)00029-3
10.1016/j.ijpharm.2017.09.003
10.1016/j.ejpb.2014.12.003
10.1016/j.ijpharm.2014.04.019
10.1080/10717540490265379
10.1016/J.TIPS.2018.02.006
10.1002/9783527648245.ch1
10.1016/j.ijpharm.2009.08.003
10.1016/j.ijpharm.2018.05.044
ContentType Journal Article
Copyright American Association of Pharmaceutical Scientists 2018
Copyright_xml – notice: American Association of Pharmaceutical Scientists 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1208/s12249-018-1075-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1530-9932
EndPage 3361
ExternalDocumentID 29948979
10_1208_s12249_018_1075_3
Genre Journal Article
GroupedDBID ---
-56
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
23M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
4.4
406
408
40D
40E
53G
5GY
5VS
67N
6J9
6NX
875
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AAKDD
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACKNC
ACMDZ
ACMJI
ACMLO
ACOKC
ACOMO
ACPIV
ACREN
ACSNA
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFGCZ
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
AOIJS
ARMRJ
AXYYD
B-.
BA0
BAWUL
BDATZ
BGNMA
BSONS
C1A
CAG
COF
CS3
CSCUP
DDRTE
DIK
DNIVK
DPUIP
E3Z
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GX1
H13
HG6
HH5
HMJXF
HRMNR
HYE
HZ~
IJ-
IKXTQ
IWAJR
IXC
IXD
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
KPH
LGEZI
LLZTM
LOTEE
M4Y
MA-
NADUK
NPVJJ
NQJWS
NU0
NXXTH
O9-
O93
O9I
O9J
OK1
OVD
P2P
PF0
PT4
QOR
QOS
R89
R9I
ROL
RPM
RPX
RSV
S16
S1Z
S27
S3A
S3B
SAP
SBL
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZN
T13
TEORI
TR2
TSG
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
XSB
YLTOR
Z45
Z7U
Z7V
Z7W
Z7X
Z81
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c410t-43174cf692d9ced874ac068d033f03519931e6cb4f917fa2e4da305711f53fd13
IEDL.DBID U2A
ISSN 1530-9932
IngestDate Fri Jul 11 15:05:04 EDT 2025
Wed Feb 19 02:35:13 EST 2025
Thu Apr 24 23:09:08 EDT 2025
Tue Jul 01 01:45:32 EDT 2025
Fri Feb 21 02:33:07 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords additive manufacturing
acetaminophen
tablets
three-dimensional printing
stereolithography
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c410t-43174cf692d9ced874ac068d033f03519931e6cb4f917fa2e4da305711f53fd13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 29948979
PQID 2060875156
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_2060875156
pubmed_primary_29948979
crossref_citationtrail_10_1208_s12249_018_1075_3
crossref_primary_10_1208_s12249_018_1075_3
springer_journals_10_1208_s12249_018_1075_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-11-01
PublicationDateYYYYMMDD 2018-11-01
PublicationDate_xml – month: 11
  year: 2018
  text: 2018-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: United States
PublicationSubtitle An Official Journal of the American Association of Pharmaceutical Scientists
PublicationTitle AAPS PharmSciTech
PublicationTitleAbbrev AAPS PharmSciTech
PublicationTitleAlternate AAPS PharmSciTech
PublicationYear 2018
Publisher Springer International Publishing
Publisher_xml – name: Springer International Publishing
References Fina, Goyanes, Madla, Awad, Trenfield, Min Kuek (CR24) 2018; 547
Goyanes, Hatton, Merchant, Basit (CR15) 2015; 484
Liu, Merchant, Kulkarni, Alkademi, Basit (CR12) 2011; 78
Kim (CR21) 1995; 12
Fina, Madla, Goyanes, Zhang, Gaisford, Basit (CR23) 2018; 541
Goyanes, Scarpa, Kamlow, Gaisford, Basit, Orlu (CR9) 2017; 530
Parojcić, Durić, Jovanović, Ibrić (CR19) 2004; 11
Reynolds, Mitchell, Balwinski (CR20) 2002; 28
Wang, Goyanes, Gaisford, Basit (CR16) 2016; 503
Fina, Goyanes, Gaisford, Basit (CR8) 2017; 529
Awad, Trenfield, Goyanes, Gaisford, Basit (CR7) 2018; 23
Goyanes, Buanz, Hatton, Gaisford, Basit (CR18) 2014; 89
Kim (CR22) 1999; 7
Skoug, Borin, Fleishaker, Cooper (CR4) 1991; 8
Trenfield, Awad, Goyanes, Gaisford, Basit (CR1) 2018; 39
Raju, Prakash, Rao, Reddy, Sreenivasulu, Narasu (CR6) 2010; 3
Karasulu, Ertan (CR3) 2002; 57
Fouassier, Lalevée (CR11) 2012
Karasulu, Ertan, Köse (CR5) 2000; 49
Goyanes, Martinez, Buanz, Basit, Gaisford (CR10) 2015; 494
Fadda, Merchant, Arafat, Basit (CR13) 2009; 382
Varum, Merchant, Goyanes, Assi, Zboranová, Basit (CR14) 2018; 468
Martinez, Goyanes, Basit, Gaisford (CR17) 2017; 532
Gökçe, Özyazici, Ertan (CR2) 2009; 5
PN Raju (1075_CR6) 2010; 3
A Goyanes (1075_CR9) 2017; 530
SJ Trenfield (1075_CR1) 2018; 39
HY Karasulu (1075_CR3) 2002; 57
F Fina (1075_CR23) 2018; 541
F Varum (1075_CR14) 2018; 468
HM Fadda (1075_CR13) 2009; 382
J Parojcić (1075_CR19) 2004; 11
C Kim (1075_CR21) 1995; 12
C Kim (1075_CR22) 1999; 7
JW Skoug (1075_CR4) 1991; 8
A Goyanes (1075_CR15) 2015; 484
JP Fouassier (1075_CR11) 2012
PR Martinez (1075_CR17) 2017; 532
F Liu (1075_CR12) 2011; 78
Atheer Awad (1075_CR7) 2018; 23
J Wang (1075_CR16) 2016; 503
HY Karasulu (1075_CR5) 2000; 49
F Fina (1075_CR8) 2017; 529
TD Reynolds (1075_CR20) 2002; 28
A Goyanes (1075_CR18) 2014; 89
A Goyanes (1075_CR10) 2015; 494
EH Gökçe (1075_CR2) 2009; 5
F Fina (1075_CR24) 2018; 547
References_xml – volume: 49
  start-page: 177
  year: 2000
  end-page: 182
  ident: CR5
  article-title: Modeling of theophylline release from different geometrical erodible tablets
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/S0939-6411(99)00082-X
– volume: 78
  start-page: 151
  year: 2011
  end-page: 157
  ident: CR12
  article-title: Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2011.01.001
– volume: 3
  start-page: 872
  year: 2010
  end-page: 876
  ident: CR6
  article-title: Effect of tablet surface area and surface area/volume on drug release from lamivudine extended release matrix tablets
  publication-title: Int J Pharm Sci Nanotech
– volume: 503
  start-page: 207
  year: 2016
  end-page: 212
  ident: CR16
  article-title: Stereolithographic (SLA) 3D printing of oral modified-release dosage forms
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2016.03.016
– volume: 23
  start-page: 1547
  issue: 8
  year: 2018
  end-page: 1555
  ident: CR7
  article-title: Reshaping drug development using 3D printing
  publication-title: Drug Discovery Today
  doi: 10.1016/j.drudis.2018.05.025
– volume: 28
  start-page: 457
  year: 2002
  end-page: 466
  ident: CR20
  article-title: Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets
  publication-title: Drug Dev Ind Pharm
  doi: 10.1081/DDC-120003007
– volume: 484
  start-page: 103
  year: 2015
  end-page: 108
  ident: CR15
  article-title: Gastrointestinal release behaviour of modified-release drug products: dynamic dissolution testing of mesalazine formulations
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2015.02.051
– volume: 12
  start-page: 1045
  year: 1995
  end-page: 1048
  ident: CR21
  article-title: Compressed donut-shaped tablets with zero-order release kinetics
  publication-title: Pharm Res
  doi: 10.1023/A:1016218716951
– volume: 5
  start-page: 421
  year: 2009
  end-page: 427
  ident: CR2
  article-title: The effect of geometric shape on the release properties of metronidazole from lipid matrix tablets
  publication-title: J Biomed Nanotechnol
  doi: 10.1166/jbn.2009.1052
– volume: 530
  start-page: 71
  year: 2017
  end-page: 78
  ident: CR9
  article-title: Patient acceptability of 3D printed medicines
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2017.07.064
– volume: 494
  start-page: 657
  year: 2015
  end-page: 663
  ident: CR10
  article-title: Effect of geometry on drug release from 3D printed tablets
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2015.04.069
– volume: 8
  start-page: 1482
  year: 1991
  end-page: 1488
  ident: CR4
  article-title: In vitro and in vivo evaluation of whole and half tablets of sustained-release Adinazolam Mesylate
  publication-title: Pharm Res
  doi: 10.1023/A:1015834114359
– volume: 57
  start-page: 939
  year: 2002
  end-page: 945
  ident: CR3
  article-title: Different geometric shaped hydrogel theophylline tablets: statistical approach for estimating drug release
  publication-title: Farmaco
  doi: 10.1016/S0014-827X(02)01297-1
– volume: 541
  start-page: 101
  issue: 1–2
  year: 2018
  end-page: 107
  ident: CR23
  article-title: Fabricating 3D printed orally disintegrating printlets using selective laser sintering
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2018.02.015
– volume: 529
  start-page: 285
  year: 2017
  end-page: 293
  ident: CR8
  article-title: Selective laser sintering (SLS) 3D printing of medicines
  publication-title: Int J Pharm
  doi: 10.1016/J.IJPHARM.2017.06.082
– volume: 7
  start-page: 237
  year: 1999
  end-page: 242
  ident: CR22
  article-title: Release kinetics of coated, donut-shaped tablets for water soluble drugs
  publication-title: Eur J Pharm Sci
  doi: 10.1016/S0928-0987(98)00029-3
– volume: 532
  start-page: 313
  year: 2017
  end-page: 317
  ident: CR17
  article-title: Fabrication of drug-loaded hydrogels with stereolithographic 3D printing
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2017.09.003
– volume: 89
  start-page: 157
  year: 2014
  end-page: 162
  ident: CR18
  article-title: 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2014.12.003
– volume: 468
  start-page: 172
  issue: 1–2
  year: 2018
  end-page: 177
  ident: CR14
  article-title: Accelerating the dissolution of enteric coatings in the upper small intestine: Evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2014.04.019
– volume: 11
  start-page: 59
  year: 2004
  end-page: 65
  ident: CR19
  article-title: An investigation into the factors influencing drug release from hydrophilic matrix tablets based on novel carbomer polymers
  publication-title: Drug Deliv
  doi: 10.1080/10717540490265379
– volume: 39
  start-page: 440
  year: 2018
  end-page: 451
  ident: CR1
  article-title: 3D printing pharmaceuticals: drug development to frontline care
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/J.TIPS.2018.02.006
– start-page: 3
  year: 2012
  end-page: 9
  ident: CR11
  article-title: Photopolymerization and photo-cross-linking
  publication-title: Photoinitiators for polymer synthesis
  doi: 10.1002/9783527648245.ch1
– volume: 382
  start-page: 56
  year: 2009
  end-page: 60
  ident: CR13
  article-title: Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2009.08.003
– volume: 547
  start-page: 44
  issue: 1–2
  year: 2018
  end-page: 52
  ident: CR24
  article-title: 3D printing of drug-loaded gyroid lattices using selective laser sintering
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2018.05.044
– volume: 8
  start-page: 1482
  year: 1991
  ident: 1075_CR4
  publication-title: Pharm Res
  doi: 10.1023/A:1015834114359
– volume: 529
  start-page: 285
  year: 2017
  ident: 1075_CR8
  publication-title: Int J Pharm
  doi: 10.1016/J.IJPHARM.2017.06.082
– volume: 468
  start-page: 172
  issue: 1–2
  year: 2018
  ident: 1075_CR14
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2014.04.019
– volume: 57
  start-page: 939
  year: 2002
  ident: 1075_CR3
  publication-title: Farmaco
  doi: 10.1016/S0014-827X(02)01297-1
– volume: 532
  start-page: 313
  year: 2017
  ident: 1075_CR17
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2017.09.003
– volume: 39
  start-page: 440
  year: 2018
  ident: 1075_CR1
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/J.TIPS.2018.02.006
– volume: 541
  start-page: 101
  issue: 1–2
  year: 2018
  ident: 1075_CR23
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2018.02.015
– volume: 382
  start-page: 56
  year: 2009
  ident: 1075_CR13
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2009.08.003
– volume: 3
  start-page: 872
  year: 2010
  ident: 1075_CR6
  publication-title: Int J Pharm Sci Nanotech
– volume: 530
  start-page: 71
  year: 2017
  ident: 1075_CR9
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2017.07.064
– volume: 78
  start-page: 151
  year: 2011
  ident: 1075_CR12
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2011.01.001
– start-page: 3
  volume-title: Photoinitiators for polymer synthesis
  year: 2012
  ident: 1075_CR11
  doi: 10.1002/9783527648245.ch1
– volume: 28
  start-page: 457
  year: 2002
  ident: 1075_CR20
  publication-title: Drug Dev Ind Pharm
  doi: 10.1081/DDC-120003007
– volume: 23
  start-page: 1547
  issue: 8
  year: 2018
  ident: 1075_CR7
  publication-title: Drug Discovery Today
  doi: 10.1016/j.drudis.2018.05.025
– volume: 484
  start-page: 103
  year: 2015
  ident: 1075_CR15
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2015.02.051
– volume: 503
  start-page: 207
  year: 2016
  ident: 1075_CR16
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2016.03.016
– volume: 11
  start-page: 59
  year: 2004
  ident: 1075_CR19
  publication-title: Drug Deliv
  doi: 10.1080/10717540490265379
– volume: 547
  start-page: 44
  issue: 1–2
  year: 2018
  ident: 1075_CR24
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2018.05.044
– volume: 89
  start-page: 157
  year: 2014
  ident: 1075_CR18
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2014.12.003
– volume: 12
  start-page: 1045
  year: 1995
  ident: 1075_CR21
  publication-title: Pharm Res
  doi: 10.1023/A:1016218716951
– volume: 7
  start-page: 237
  year: 1999
  ident: 1075_CR22
  publication-title: Eur J Pharm Sci
  doi: 10.1016/S0928-0987(98)00029-3
– volume: 494
  start-page: 657
  year: 2015
  ident: 1075_CR10
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2015.04.069
– volume: 5
  start-page: 421
  year: 2009
  ident: 1075_CR2
  publication-title: J Biomed Nanotechnol
  doi: 10.1166/jbn.2009.1052
– volume: 49
  start-page: 177
  year: 2000
  ident: 1075_CR5
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/S0939-6411(99)00082-X
SSID ssj0023193
Score 2.570184
Snippet Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3355
SubjectTerms Acetaminophen - chemistry
Biochemistry
Biomedical and Life Sciences
Biomedicine
Biotechnology
Drug Liberation
Pharmacology/Toxicology
Pharmacy
Polyethylene Glycols - chemistry
Powders
Printing, Three-Dimensional
Research Article
Stereolithography
Tablets - chemistry
Technology, Pharmaceutical - methods
Theme: Printing and Additive Manufacturing
Title Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D-Printed Tablets
URI https://link.springer.com/article/10.1208/s12249-018-1075-3
https://www.ncbi.nlm.nih.gov/pubmed/29948979
https://www.proquest.com/docview/2060875156
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZSwMxEB48XnwRb-tFBBGvxd3Nno9FrbcU24I-hd0cKuiudLcP_fdO9miRquB7Dsg3yXyTSb4B2EOKEfvSk4aSFgYobhwaQSwtgwdhbCkhIl7cd9w_eFc95-bJfar-cWf1a_c6JVmc1IUCghmcZjoHpN_2aDlS3zXoNMy6OnRHI-7ZzVGUhTZFq_Tlj92-O6AJVjmRES0cTWsB5iuGSJolpIswJZMl2G-XEtPDE9Id_5jKTsg-aY_Fp4fLEF3XVUdIqsilTD9k3h-SNCHI9Mh5f_BCHtHToO8i7bJcd6YbdnB5pX4K91pKWL9xctC5ax4Sem60-1pTQpCu_mWVZyvQa110z66MqoyCwR3LzA1NERyuvNAWIZci8B0EwAuESanSeURkKJb0eOwoDN1UZEtHRHgK-JalXKqERVdhJkkTuQ6EIx2MfIksQUU4ih0pJGQ0Njl2c2LhN8Cs15bxSmNcl7p4ZzrWQDhYCQdDOJiGg9EGHI26fJYCG3813q0BY7gNdG4jSmQ6yJhtelqbH6PRBqyVSI6GQ4_rBKEfNuC4hpZVOzX7fa6Nf7XehDm7sDF9ObMFM3l_ILeRruTxDsw2L59vL3YKM_0CHHfjfQ
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JTsMwEB1BOcAFsVNWIyHE0ogkTrMcK6AUKKiCVuJmJV4ACRLUpIf-PeMsRYhF4u5F8rM9bzzjNwD7SDEiT7rSUNJCB6UZBYYfScvgfhBZSoiQ5-8dt3duZ-BcPzYfy3_caZXtXoUk85s6V0Aw_dNUx4B0bo-WI_WaBp2GGeQCvs7jGtitiZeFe4qW4csfu301QN9Y5beIaG5o2gswXzJE0iogXYQpGS_BQa-QmB43SP_zx1TaIAek9yk-PV6G8KqqOkISRS5l8iaz4ZgkMUGmR86Hoydyj5YGbRfpFeW6U93wAZdX6lS450LC-oWTw4du64jQc6M31JoSgvT1L6ssXYFB-6J_1jHKMgoGdywzMzRFcLhyA1sEXArfcxAA1xcmpUrHEZGhWNLlkaPQdVOhLR0R4i3gWZZqUiUsugq1OInlOhCOdDD0JLIEFeIodqiQkNHI5NjNiYRXB7NaW8ZLjXFd6uKVaV8D4WAFHAzhYBoORutwPOnyXghs_NV4rwKM4THQsY0wlskoZbbpam1-9EbrsFYgORkOLa7jB15Qh5MKWlae1PT3uTb-1XoXZjv92y7rXt3dbMKcne83_VCzBbVsOJLbSF2yaCffqh_W5-Tc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB4VKiEuVV-U7dOVKgR0I-I4m8dx1e0CLaAIdiVuVuIHRaIJ2mQP--87s04WIdpKXCPbkfyNPd947G8AviDFKGITGc8ajgHKoEi9pDDcU0lacKt1rpbnHadn0dE0_HE5uGzrnNbdbfcuJeneNJBKU9kc3Grr1BD85KCmfBDd8yFp0njgiTV4irsxJ7OeBsNVxIVfRJvK_Gu3-87oAcN8kB1dOp3xc3jWskU2dPC-gCemfAk7mZObXvTZ5O71VN1nOyy7E6JevIL8uKtAwirLDk312zSzBatKhqyPjWbzK3aOXgf9GMtc6e6aGl7gVBu6FvfLyVlfK7Z7cTLcY2LkZTPSl9BsQi-umvo1TMffJ9-OvLakgqdC7jce0YVQ2SgNdKqMTuIQwYgS7QthKaeIbIWbSBWhxTDO5oEJdY47Qsy5HQirudiC9bIqzTYwhdQwjw0yBpvjKEFukZyJwlfYLSx03AO_m1upWr1xKntxIynuQDikg0MiHJLgkKIH-6sut05s43-NP3eASVwSlOfIS1PNaxn4Een0Y2TagzcOydVw6H3DJI3THnztoJXtqq3__a-3j2r9CTay0VieHJ_9fAebwdLc6MzmPaw3s7n5gCymKT4uLfUPEqfpGA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+Geometry+on+the+Drug+Release+Profiles+of+Stereolithographic+%28SLA%29+3D-Printed+Tablets&rft.jtitle=AAPS+PharmSciTech&rft.au=Martinez%2C+Pamela+Robles&rft.au=Goyanes%2C+Alvaro&rft.au=Basit%2C+Abdul+W&rft.au=Gaisford%2C+Simon&rft.date=2018-11-01&rft.issn=1530-9932&rft.eissn=1530-9932&rft.volume=19&rft.issue=8&rft.spage=3355&rft_id=info:doi/10.1208%2Fs12249-018-1075-3&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-9932&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-9932&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-9932&client=summon